Teresa Deluca Buys 10,000 Shares of Surgery Partners (NASDAQ:SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY) Director Teresa Deluca bought 10,000 shares of Surgery Partners stock in a transaction on Tuesday, August 18th. The shares were purchased at an average price of $14.35 per share, for a total transaction of $143,500.00. Following the acquisition, the director directly owned 66,843 shares in the company, valued at approximately $959,197.05. This trade represents a 17.59% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.

Surgery Partners Stock Up 2.5%

Shares of NASDAQ:SGRY opened at $13.94 on Friday. Surgery Partners, Inc. has a 52-week low of $11.41 and a 52-week high of $24.10. The firm has a market capitalization of $1.83 billion, a P/E ratio of -19.91, a P/E/G ratio of 3.69 and a beta of 1.91. The stock has a 50 day moving average price of $15.59 and a 200-day moving average price of $14.38. The company has a debt-to-equity ratio of 1.18, a quick ratio of 1.78 and a current ratio of 1.95.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Monday, August 10th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.04. Surgery Partners had a positive return on equity of 0.88% and a negative net margin of 2.63%.The company had revenue of $848.90 million for the quarter, compared to analysts’ expectations of $830.03 million. During the same period in the prior year, the firm earned $0.17 earnings per share. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. As a group, equities research analysts anticipate that Surgery Partners, Inc. will post 0.25 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on SGRY shares. Cantor Fitzgerald restated an “overweight” rating and issued a $18.00 price objective on shares of Surgery Partners in a report on Tuesday, August 11th. TD Cowen boosted their price target on Surgery Partners from $17.00 to $19.00 and gave the stock a “buy” rating in a research report on Tuesday, August 11th. Zacks Research downgraded Surgery Partners from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 10th. Jefferies Financial Group reaffirmed a “buy” rating and set a $17.00 price objective on shares of Surgery Partners in a research report on Wednesday, May 6th. Finally, Benchmark reiterated a “buy” rating on shares of Surgery Partners in a research note on Tuesday, August 11th. Seven research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $19.45.

Hedge Funds Weigh In On Surgery Partners

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. PNC Financial Services Group Inc. raised its stake in shares of Surgery Partners by 239.6% in the first quarter. PNC Financial Services Group Inc. now owns 2,907 shares of the company’s stock worth $35,000 after purchasing an additional 2,051 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new position in Surgery Partners in the 2nd quarter worth about $38,000. Fifth Third Bancorp raised its position in Surgery Partners by 5,324.0% in the 1st quarter. Fifth Third Bancorp now owns 4,068 shares of the company’s stock worth $48,000 after buying an additional 3,993 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its stake in Surgery Partners by 45,640.0% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,287 shares of the company’s stock valued at $49,000 after acquiring an additional 2,282 shares during the period. Finally, Aquatic Capital Management LLC bought a new position in Surgery Partners during the 3rd quarter valued at about $121,000.

Surgery Partners Company Profile

Surgery Partners, Inc operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care.